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Abstract: The overall aim of this study was to estimate the contribution of genetic factors to the etiology of hearing 
loss (HL) in two counties in the Brazilian northeastern region. A cross-sectional study, based on the key informant 
approach (KI) was conducted in Queimadas and Gado Bravo counties (Paraíba, Northeast Brazil). The sample con-
sisted of 182 patients with HL. Genetic screening of the most frequent mutations associated with HL was performed 
for all samples. DFNB1 mutations were the most frequently found in both counties. The c.35delG mutation was 
detected in homozygosis in seven non-syndromic probands in Queimadas (7/76, 9.2%) and only a single homozy-
gote with this mutation was found in Gado Bravo (1/44, 2.3%). We also detected the del(GJB6-D13S1854) muta-
tion in non-syndromic probands from Gado Bravo (2/44, 4.5%). The c.189C>A (p.TyrY63*) mutation in the CLRN1 
gene was detected in homozygosis in 21/23 Usher syndrome patients from Gado Bravo and it was not found in 
Queimadas. Cases with probable genetic etiology contributed approximately to half of HL probands in each county 
(54.6% in Gado Bravo and 45.7% in Queimadas). We confirm the importance of DFNB1 locus to non-syndromic HL 
but we show that the frequency of mutations in the northeastern region differs somewhat from those reported in 
southeastern Brazil and other populations. In addition, the extremely high frequency of individuals with Usher syn-
drome with c.189C>A variation in CLRN1 indicates the need for a specific screening of this mutation.
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Introduction
Hearing loss (HL) affects approximately 360 
million people worldwide [1] with an incidence 
of 1 in 1,000 births [2]. In Brazil, about 2 million 
people are affected by this condition and 
approximately 650,000 of these live in the 
northeastern region [3]. The northeastern 
region is the poorest one in the country. The 
highest frequencies of consanguineous mar-
riages are observed in this region [4, 5].
About half of all HL cases in developed coun-
tries are due to genetic factors, and 30% of 
these are syndromic cases [6]. More than 400 
syndromes were described presenting HL asso-
ciated with other clinical abnormalities [7], and 
Usher syndrome (US) is the most common type 
of autosomal recessive syndromic hearing loss 
(ARSHL) disorder [8, 9]. The prevalence of this 
syndrome was estimated as 1 per 6,000 indi-
viduals in the United States [10]. Usher syn-
drome, characterized by combined retinitis pig-
mentosa with HL, can be classified in three 
main subtypes (USH1, USH2 and USH3), to 
which nine, four and two loci have been 
mapped, respectively, with a total of 11 genes 
having been identified up to now [11].
Among non-syndromic genetic cases, 80% have 
an autosomal recessive mechanism (ARNSHL) 
[12, 13]. The autosomal dominant mechanism 
corresponds to 14 to 24% of genetic cases; 2 to 
3% are due to X-linked HL and 1% is due to 
maternal inheritance [9, 14].
The locus DFNB1, that houses GJB2 and GJB6 
genes [15], is the most frequently associated 
with ARNSHL [16], the GJB2 gene being respon-
sible for about 50% of the recessive deafness 
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cases [17]. In different populations, the most 
frequent mutation associated with HL is the 
c.35delG in the GJB2 gene, found in homozygo-
sis from 10% to 63% of non-syndromic HL 
cases [17, 18]. Other frequent mutations in this 
gene are the c.167delT, c.235delC, p.Trp24* (or 
c.71G>A) and p.Arg143Trp (or c.427T>C), which 
are frequently found in Ashkenazi Jews, in 
Asian, Indian and African populations, respec-
tively [16, 19-21].
Four large deletions near the GJB6 gene were 
identified and they generally act as a second 
recessive mutation in the DFNB1 locus in 
affected individuals [22-26]. The del(GJB6-
D13S1830) and del(GJB6-D13S1854) are 
more frequently found in European and 
European-derived populations [23]. The sec-
ond most important locus related to autosomal 
recessive HL is the DFNB4 locus, which 
encodes the SLC26A4 gene; more than 200 
mutations in the coding region of this gene 
have been described [27, 28]. In the mitochon-
drial DNA, the most frequent mutation found 
among people with non-syndromic HL is 
m.1555A>G, in the MTRNR1 gene [29].
In Brazil, the frequency of mutations in the 
DFNB1 locus varies from 1% to 18.2% in non-
syndromic hearing loss cases and the observed 
frequencies of c.35delG mutation in homozygo-
sis ranged from 1.3% to 15.2% [30-38]. Most 
studies on genetic HL in Brazilian samples were 
concentrated in the southeastern region, and 
only one previous study was conducted in the 
northeastern region [37].
The overall aim of this study was to estimate 
the contribution of genetic factors to the etiol-
ogy of HL in two counties located in the Brazilian 
northeastern region. The accurate character-
ization of causes of HL and the role of genetic 
factors may contribute to the establishment of 
public medical policies for these populations.
Materials and methods
Population sample
A cross-sectional study, based on the key infor-
mant approach (KI), in order to detect disabili-
ties in resource-poor countries [39-41], was 
conducted in the Queimadas and Gado Bravo 
counties, with 41,054 and 8,376 inhabitants, 
respectively [3], in the state of Paraíba, 
Northeast of Brazil (Figure 1). All individuals 
who had been detected by the Community 
Health Agents as presenting HL were invited to 
participate in genetic and audiological evalua-
tion. Individuals presenting the first symptoms 
after 60 years of age were excluded.
The research was approved by the Ethics com-
mittees from Universidade Estadual da Paraíba 
(Process 0357.0.133.133-11) and from the 
Instituto de Biociências da Universidade de 
São Paulo (Process 126/2011 - FR. 458729).
The sample consisted of 182 patients with HL 
(106 patients from Queimadas and 76 from 
Gado Bravo), from which 136 were unrelated 
probands (81 from Queimadas and 55 from 
Gado Bravo). The Brazilian northeastern popu-
lation is trihybrid, resulting from the admixture 
Figure 1. (A) Map of Brazil. The state of Paraíba is highlighted in (B). (B) 
Counties sampled in this research (Queimadas and Gado Bravo).
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of European, African and Native American indi-
viduals. Most, if not all subjects from our sam-
ple, fall into this category. A semi-structured 
interview was conducted to collect clinical 
information and family data.
Audiological evaluation was carried out by audi-
ologists from Universidade Federal da Paraíba. 
Fundoscopic examination was performed by an 
ophthalmologist from the Universidade Federal 
de Campina Grande in 33 patients from Gado 
Bravo who reported visual impairment associ-
ated with HL, in order to evaluate the presence 
of retinitis pigmentosa.
Molecular analysis
DNA from blood samples of about 10 ml was 
extracted using the Autopure LS device by 
Gentra Systems, available at the Centro de 
Estudos do Genoma Humano (USP, São Paulo, 
Brazil).
The c.35delG and c.167delT mutations in the 
GJB2 gene, and m.1555A>G mutation in the 
mitochondrial gene (MTRNR1) were screened 
by polymerase chain reaction (PCR), followed 
by DNA digestion using restriction enzymes 
BstN I, Pst I and Hae III, respectively [16, 42, 
43]. Digestion of the PCR products was per-
formed with 10 units of each enzyme and the 
products were subjected to gel electrophoresis 
in a 6% polyacrylamide gel and visualized after 
staining with silver nitrate impregnation [44]. 
The del(GJB6-D13S1830) and del(GJB6-D13- 
S1854) were detected by specific multiplex 
PCR [26] and the products were visualized on 
agarose gel after staining with 2% SYBR Safe 
(Life Technologies, Carlsbad, CA, USA). This 
screening was performed in all HL patients.
GJB2 sequencing was performed to confirm the 
mutations detected in the previous screenings, 
either in homozygosis or heterozygosis. It was 
also performed to identify a second recessive 
mutation in samples from heterozygote individ-
uals and in samples from probands of pedi-
grees with probable autosomal recessive or 
autosomal dominant inheritance. Two pairs of 
primers were used for GJB2 gene sequencing 
(1F: 5’-3’ ACC TGT GGT TTT GAG GTT GTG T and 
1R: 5’-3’ ACC TTC TGG GTT TTG ATC TCC TC; 2F: 
5’-3’ GGA AGT TCA TCA AGA AGG GGG and 2R: 
5’-3’ TGA GCA CGG GTT GCC CTC ATC). The 
reaction products were analyzed in the ABI 
3730 DNA Analyzer equipment (Applied 
Biosystems, Carlsbad, CA, USA) at the Centro 
de Estudos do Genoma Humano, Departamento 
de Genética e Biologia Evolutiva (São Paulo, 
Brazil). The results were analyzed using the 
software Chromas Lite (http://www.chromas-
lite.softpedia.com) and MEGA5 (http://www.
megasoftware.net).
Genomic scanning was performed by 50K SNP 
arrays genotyping in samples of four siblings 
affected by Usher syndrome (GeneChip ® 
Human Mapping Array Hind 240, Affymetrix, 
Santa Clara, CA, USA). The DNA was diluted to 
the original concentration of 50 ng/μl and 5 μl, 
and fragmented by HindIII, as per the manufac-
turer’s protocol (Uniscience website; GeneChip 
Mapping 10K 2.0 Assay Manual). The analysis 
was performed with GeneChip Scanner 3000 
equipment and the results were analyzed by 
GeneChip Operating Software (Affymetrix, San- 
ta Clara, CA, USA).
The results of 50K SNP arrays were analyzed 
for obtaining multipoint LOD scores. The 
Alohomora software was used to convert the 
obtained data from the Affymetrix genotype 
platform into files for linkage analysis (Santa 
Clara, CA, USA), and Pedcheck was used for 
checking Mendelian segregation [45]. Merlin 
software was used to obtain multipoint LOD 
scores [46]. The disease was analyzed as an 
autosomal recessive trait and the disease 
allele frequency was 0.0001. Marker allele fre-
quencies were calculated using the data from 
the family. The recombination rate was ass- 
umed to be similar in both genders. The muta-
tion rate of the gene was considered to be zero.
Four microsatellites mapped near the SLC26A4 
gene were genotyped (D7S2420, D7S496, 
D7S2456 and D7S799) and also the molecular 
marker D7S2459, located at the intron 11 of 
this gene, was analyzed. This analysis was per-
formed in samples from individuals from auto-
somal recessive hearing loss (ARHL) pedigrees 
without detected mutations in previous molec-
ular screenings (49 samples from 24 pedi-
grees). The primers for amplification are 
described in databases (http://genome.ucsc.
edu/ and http://www.ncbi.nlm.nih.gov/), except 
for the D7S799 marker, for which the reverse 
primer was designed using PRIMER 3 (http://
primer3.sourceforge.net/).
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Microsatellites mapped near MYO7A (11q13) 
and CLRN1 (3q25) genes were genotyped in 
four sibling samples affected by Usher syn-
drome: 11 microsatellites mapped near CLRN1 
gene (D3S1566, D3S3681, D3S1271, D3S- 
1278, D3S1267, D3S1292, D3S1569, D3S- 
1279, D3S1614, D3S1262 and D3S1580), 
and 11 microsatellites near MYO7A gene 
(D11S904, D11S935, D11S905, D11S4191, 
D11S987, D11S1314, D11S937, D11S4175, 
D11S898, D11S908 and D11S925). The prim-
ers are available from ABI PRISM ® Linkage 
Mapping Set v. MD10-2.5 kit from Applied 
Biosystems (Foster City, CA, USA). The polymor-
phic fragments were subjected to capillary 
electrophoresis using the ABI 3730 DNA 
Analyzer apparatus (Applied Biosystems, 
Carlsbad, CA, USA) and analyzed using the 
GeneMapper software (Applied Biosystems, 
Carlsbad, CA, USA).
SLC26A4 exon sequencing was performed in 
samples from three probands from pedigrees 
in which microsatellite segregation was com-
patible with SLC26A4 linkage. The primers for 
amplification of the coding exons of this gene 
are described [47-49], with the exception of 
primers for amplification of exons 11, 12, 15 
and 17, which were designed using PRIMER 3 
(http://primer3.sourceforge.net/). All samples 
from Usher syndrome patients were subjected 
to CLRN1 gene sequencing. Primers to amplify 
exon 1 were designed by PRIMER 3 (1F: 5’-3’ 
GGC CGG AGT GTT CAG TTT T and 1R: 5’-3’ TTT 
CAT ATG GTT CAC ACC GAT T). Primers for exons 
2, 3, 3b and 3c were previously described [50, 
51].
The MLPA technique was applied to samples of 
10 probands with a single recessive mutation 
in heterozygosity in the DFNB1 locus and in 2 
samples from pedi-
grees compatible wi- 
th X-linked HL, using 
the commercial kit 
SALSA P163-D1 GJB-
WFS1 (MRC Holland, 
2012). The amplifica-
tion products were 
obtained in accorda- 
nce with the manu-
facturer’s instructio- 
ns and subjected to 
capillary electropho-
resis using the ABI 
Table 1. Demographic, socioeconomic data and individuals sampled in 
both counties
Counties
Gado Bravo Queimadas
Population (inhabitants) 8,376 41,049
Population Density (pop. per km²) 43.53 102.17
Human Development Index (HDI) 0.527 0.613
Gross Domestic Product (GDP) per capita in Dollars U$ 1,702 U$ 2,119
Total of HL individuals from county (reported by CHA) 85 (1.01%) 150 (0.37%)
HL individuals sampled 76 (89.4%) 106 (70.7%)
HL individuals sampled in the total population of county 0.91% 0.26%
3730 DNA Analyzer instrument (Applied 
Biosystems, Carlsbad, CA, USA). The results 
were analyzed using the Gene Marker software 
(http://www.softgenetics.com/GeneMarker.
html).
Results and discussion
Characterization of the populations
Table 1 lists demographic and socioeconomic 
data, and number of sampled individuals with 
HL in each county [3, 52]. The Brazilian census 
[3] indicated that there are about 650,000 peo-
ple with hearing impairment in the northeast-
ern region of Brazil, 48,000 of them in the state 
of Paraíba. In Gado Bravo and Queimadas 
counties, the census registered 232 (2.8%) and 
427 (1.1%) people with HL respectively; these 
frequencies are higher than the ones reported 
in the present study (76 and 106; 0.91% and 
0.27%, respectively). These discrepancies 
could be explained by the strategy of Brazilian 
census: information was registered without 
clinical confirmation; besides, people showing 
the first HL symptoms after 60 years were prob-
ably included.
Interestingly, the proportion of affected individ-
uals in Gado Bravo was three times higher than 
Queimadas (0.91% and 0.27%, respectively). 
Excluding the Usher syndrome cases from both 
counties (23 patients from Gado Bravo and one 
patient from Queimadas), the frequency of HL 
cases in Gado Bravo is still two times higher 
than Queimadas (0.63% and 0.25%, respec-
tively). The parental consanguinity rate did not 
explain the greater number of HL cases in Gado 
Bravo (21.8%) as compared to Queimadas 
(28.4%). Data for HDI and GDP per capita 
income of the two counties were compared [52] 
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and both counties are grouped in the range of 
average HDI (500-799) and have similar GDP 
per capita income. They do not explain the dif-
ferences in prevalence between both comm- 
unities.
Syndromic hearing loss
Syndromic HL was identified in 17 out of 136 
probands (12.5%), being 12 from Gado Bravo 
and five from Queimadas. One patient of the 
former county had profound bilateral HL, tele-
canthus, synophrys, hypochromic bright blue 
color of the iris, and a frontal white hair fore-
lock, being a case of Waardenburg type I syn-
drome (1/12, 8.3%). The remaining 11 pro-
bands from Gado Bravo had HL associated with 
retinitis pigmentosa (Usher syndrome). In Quei- 
madas, three probands had mental retardation 
(3/5, 60%), one was affected by a polyneuropa-
thy syndrome (1/5, 20%) and one proband had 
retinitis pigmentosa (US; 1/5, 20%).
The frequency of Usher syndrome in Gado 
Bravo was calculated as one per 364 individu-
als, about 16 times higher than in the US popu-
lation prevalence [10]. Samples of four siblings 
affected by Usher syndrome from Gado Bravo 
were subjected to 50k SNP array genotyping 
assay and the corresponding result of the LOD 
score analysis is shown in Figure 2. Eleven 
regions with LOD scores near 1.8 were found 
(in chromosomes 1, 3, 6, 8, 11, 13, 14, 16 and 
18). Two of these mapped regions had genes 
previously associated with Usher syndrome 
(CLRN1 and MYO7A genes). The samples were 
subjected also to microsatellite genotyping 
with markers mapped near CLRN1 and MYO7A 
genes. This allowed exclusion of MYO7A gene 
(11q13.5) as a candidate. Microsatellites near 
the region of CLRN1 segregated with the phe-
notype and this gene was selected for sequenc-
ing. The c.189C>A (p.Tyr63*) mutation, local-
ized in exon 1 of this gene, was detected in 
homozygosis in all affected siblings. Samples 
Figure 2. Multipoint parametric LOD score analyses from samples of four siblings with Usher syndrome. The map 
distance (cM) was converted (bp) using as reference the genome GRCh37/hg19.
Table 2. Mutation frequencies in the GJB2, GJB6 and MTRNR1 genes in the group of non-syndromic 
HL probands
Genes Mutations
Counties
Gado Bravo Queimadas
Homozygosis Heterozygosis Homozygosis Heterozygosis
GJB2 c.35delG 1/44 (2.3%) 3/44 (6.8%) 7/76 (9.2%) 7/76 (9.2%)
c.167delT 0/44 0/44 0/76 0/76
p.Trp24* (c.71G>A) 0/44 3/44 (6.8%) 0/76 0/76
GJB6 del(GJB6-D13S1830) 0/44 0/44 0/76 0/76
del(GJB6-D13S1854) 0/44 2/44 (4.5%) 0/76 0/76
MTRNR1 m.1555A>G 0/44 0/44 0/76 0/76
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from the remaining Usher syndrome patients 
(19 from Gado Bravo and one from Queimadas) 
were also subjected to sequencing and 21/23 
patients from Gado Bravo presented this muta-
tion in homozygosity, which was not detected in 
the only affected subject from Queimadas. This 
mutation has been previously described in 
studies of Spanish populations [50, 51], and its 
high frequency could be explained by a founder 
effect. 
Non-syndromic hearing loss
A total of 76 and 44 probands in Queimadas 
and Gado Bravo, respectively, had non-syn-
dromic HL. As summarized in Table 2, seven 
probands from Queimadas were homozygous 
as to the c.35delG mutation in the GJB2 gene 
(7/76, 9.2%) and seven presented this muta-
tion in heterozygosis (7/76, 9.2%). The estimat-
ed genotype frequencies in the sample of non-
syndromic probands are shown in Table 3. This 
result is similar to other Brazilian studies (1.3% 
to 15.2%; Table 4). In Gado Bravo, only one 
homozygote with c.35delG mutation was found 
(1/44, 2.3%) and three were c.35delG heterozy-
gotes (3/44, 6.8%). The frequency of c.35delG 
in this county was surprisingly lower than 
expected. The higher frequency of this muta-
tion in Queimadas might be explained by found-
er effect, since six probands had a common 
ancestor.
Two probands had the del(GJB6-D13S1854) of 
the GJB6 gene in heterozygosis (2/44, 4.5%) in 
Gado Bravo and this frequency was higher than 
two other Brazilian studies (1.3% and 0.5%; 
Table 4). This mutation was not detected in 
Queimadas. The del(GJB6-D13S1830) muta-
tion was not identified in the sampled counties, 
as well as in other studies involving populations 
of Brazilian northern and northeastern regions 
[36, 37]. This result is somewhat unexpected, 
because it is the second most frequent muta-
tion associated with HL in southeastern popu-
lations in Brazil [30, 33-35, 38]. The c.167delT 
and m.1555A>G mutations were not detected 
in either counties. 
Sequencing of the GJB2 gene allowed identifi-
cation of the p.Trp24* (c.71G>A) in three non-
syndromic probands from Gado Bravo (3/44, 
6.8%). In two cases, the mutation was present 
in compound heterozygosis with c.35delG, and 
in the third case, a second mutation was not 
found. This mutation is found in high frequency 
in individuals from Asia and Romani ethnicity 
(Indians living as nomads in Europe commonly 
referred to as “Gypsies”) [53, 54]. The largest 
Gypsy community in Brazil is located the county 
of Sousa [55], far 354 km from Gado Bravo. We 
speculate that this mutation was introduced in 
Gado Bravo by this Gypsy community.
The frequencies of DFNB1 locus mutations 
(cases with two pathogenic mutations) were 
11.4% in Gado Bravo and 9.2% in Queimadas. 
This result is similar to the frequencies 
observed in other Brazilian studies, with fre-
quencies ranging from 1% to 18.2% (Table 4). 
Four non-pathogenic variants, not shown in 
Tables 2 and 3, were also detected (c.-
22-12C>T, c.-15C>T, c.1-6T>A and c.79G>A).
The MLPA analysis of 10 samples from pro-
bands with a single recessive mutation detect-
ed in the DFNB1 locus and from the two 
patients with X-linked HL revealed no copy 
number variations (CNV).
Segregation studies with microsatellites 
mapped near to the SLC26A4 gene were per-
Table 3. Genotype Frequencies in non-syndromic probands with HL
Genotypes
Number of non-syndromic probands 
with the genotype in the total sample
Number of non-syndromic probands 
with the genotype among the total of 
genotypes with pathogenic mutations
Queimadas Gado Bravo Queimadas Gado Bravo
c.35delG/c.35delG 7/76 (9.2%) 1/44 (2.3%) 7/14 (50%) 1/7 (14.3%)
c.35delG/+ 7/76 (9.2%) 1/44 (2.3%) 7/14 (50%) 1/7 (14.3%)
c.35delG/del(GJB6-D13S1854) 0/76 1/44 (2.3%) 0/14 1/7 (14.3%)
c.35delG/p.Trp24* (c.71G>A) 0/76 2/44 (4.5%) 0/14 2/7 (28.6%)
del(GJB6-D13S1854)/+ 0/76 1/44 (2.3%) 0/14 1/7 (14.3%)
p.Trp24* (c.71G>A)/+ 0/76 1/44 (2.3%) 0/14 1/7 (14.3%)
The signal + means wild sequence allele.
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Table 4. Frequency of DFNB1 mutations in non-syndromic HL probands in several regions of Brazil
Genotype (DFNB1)
Campinas/ 
SP
São José do  
Rio Preto/SP
Brazil/Several  
Regions
São Paulo/ 
SP
Vitória/ 
ES
Belém/ 
PA
Marília/ 
SP
Monte Santo/ 
BA
Campinas/ 
SP
Gado Bravo/ 
PB
Queimadas/ 
PB
c.35delG/c.35delG 2/75  
(2.7%)
5/33  
(15.2%)
41/645  
(6.4%)
22/300  
(7.3%)
3/77  
(3.9%)
1/77  
(1.3%)
N 8/61  
(13.1%)
14/100  
(14%)
1/44  
(2.3%)
7/76  
(9.2%)
c.35delG/? 2/75  
(2.7%)
3/33  
(9.1%)
36/645  
(5.6%)
5/300  
(1.7%)
4/77  
(5.2%)
6/77  
(7.8%)
7/101  
(6.9%)
1/61  
(1.6%)
3/100  
(3%)
3/44  
(6.8%)
7/76  
(9.2%)
c.35delG/Pathogenic mutation N N 4/645  
(0.6%)**
7/300  
(2.3%)
N* N NA N 1/100  
(1%)
2/44  
(4.5%)
N
Other two pathogenic mutations in homozygosis  
or compound heterozygosis in the GJB2 gene
1/75  
(1.3%)
N 4/645  
(0.6%)**
1/300  
(0.3%)
N* N NA N 1/100  
(1%)
N N
GJB2 pathogenic mutation in heterozygosis/ 
del(GJB6-D13S1830)
NA 1/33  
(3%)
4/645  
(0.6%)
3/300  
(1%)
1/77  
(1.3%)
N 1/101  
(1%)***
N 1/100  
(1%)
N N
del(GJB6-D13S1830)/del(GJB6-D13S1830) NA N 2/645  
(0.3%)
N N N N N N N N
GJB2 pathogenic mutation in heterozygosis/ 
del(GJB6-D13S1854)
NA NA 3/645  
(0.5%)
N 1/77  
(1.3%)
NA N N N 2/44  
(4.5%)
N
del(GJB6-D13S1854)/del(GJB6-D13S1854) NA NA N N N NA N N N N N
Total of patients with two pathogenic mutations  
in the DFNB1 locus
3/75  
(4%)
6/33  
(18.2%)
58/645  
(9%)
33/300  
(11%)
5/77  
(6.5%)
1/77  
(1.3%)
1/101  
(1%)
8/61  
(13.1%)
17/100  
(17%)
5/44  
(11.4%)
7/76  
(9.2%)
Reference [31] [30] [32] [33] [34] [36] [35] [37] [38] Present  
study
Present  
study
Table key: NP – Molecular test not performed; N – Mutation not detected. *Only some mutations tested; **Some patients selected for study by GJB2 gene sequencing; ***Test performed only in patients with the c.35delG mutation in heterozy-
gosis.
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formed in 24 ARNSHL pedigrees without 
detected mutations in the DFNB1 locus. In 21 
pedigrees, linkage to SLC26A4 gene was 
excluded. Thus, three probands had all the 
SLC26A4 exons completely analyzed by 
sequencing, but no pathogenic mutation was 
detected. Screening of this gene is recom-
mended in cases with Enlarged Vestibular 
Aqueduct (EVA) or Mondini dysplasia [27, 
56-58], and given the poverty and difficulties in 
accessing health services, this diagnosis was 
not possible in both counties. These results 
suggest that mutations in SLC26A4 are not a 
frequent cause of ARNSHL in these counties.
The contribution of genetics to the etiology of 
hearing loss
All probands were classified according to the 
most likely cause of HL and the frequencies are 
shown in Table 5. Cases with probable genetic 
etiology contributed approximately to half of HL 
probands in each county (54.6% in Gado Bravo 
and 45.7% in Queimadas), and, surprisingly, 
these frequencies are comparable to those 
observed in developed countries [9, 14, 59]. 
Both counties were selected because of previ-
ous information that HL was frequent. Thus, 
these figures are probably above average val-
ues for Brazil, and should not be extrapolated. 
Among genetic cases, AR inheritance was the 
most frequent in both counties (86.6% in Gado 
Bravo and 59.4% in Queimadas). In approxi-
mately half of ARNSHL cases from Gado Bravo 
a pathogenic mutation was detected (in homo-
zygosis or compound heterozygosis) in DFNB1 
locus, which is expected, according to literature 
[9]. However, mutations in this locus explained 
only 23% of the ARNSHL cases in Queimadas. 
One could argue that mutations in other loci 
than DFNB1 and DFNB4 (SLC26A4 gene) would 
be present and could explain the high frequen-
cy of AR cases in both counties, and the large 
frequency of DNFB1 negative cases of ARNSHL 
in Queimadas. A large number of cases of auto-
somal dominant HL cases in Queimadas 
(14/37, 37.8%) was found, which corresponds 
to a higher frequency of this type of transmis-
sion when compared to other samples (14-
24%) [9].
Our survey indicated that at near 50% of the HL 
cases were genetically determined in the sam-
pled counties, suggesting the need of medical 
and community genetics services, as it has 
been suggested by World Health Organization 
[60]. In the present study, we showed that fre-
quency of mutations in Northeast region differs 
somewhat from those reported in southeastern 
Brazil and other populations, suggesting a spe-
cific strategy of screening for genetic HL. 
According to our results, the cheapest and the 
most appropriate strategy would be as follows: 
1) PCR-RFLP to screen the c.35delG mutation; 
2) Multiplex PCR to detect del(GJB6-D13S1830) 
and del(GJB6-D13S1854) mutations in all 
patients; 3) GJB2 gene sequencing in patients 
with c.35delG in heterozygosis or with del(GJB6-
D13S1830) and del(GJB6-D13S1854) muta-
tions in heterozygosis; 4) GJB2 gene sequenc-
ing in probands with HL from pedigrees pre-
senting with ARHL; 5) Screening of c.189C>A 
(p.Tyr63*) mutation in CLRN1 in probands with 
Usher syndrome from this region.
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